Company performance
Current Price
as of Jan 21, 2025$2.34
P/E Ratio
26.63
Market Cap
$9.6B
- IRBT
Description
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
Metrics
Overview
- HQWuxi, JS
- SectorHealth Technology
- IndustryBiotechnology
- Ticker2269
- Price$2.338265-2.67%
Trading Information
- Market cap$9.60B
- Float85.18%
- Average Daily Volume (1m)40,094,716
- Average Daily Volume (3m)49,806,721
- EPS$0.90
Company
- Revenue$18.82B
- Rev growth (1yr)6.01%
- Net incomeN/A
- Gross marginN/A
- EBITDA margin31.22%
- EBITDAN/A
- EVN/A
- EV/Revenue6.66
- P/E26.63
- P/S4.18
- P/B1.73
Documents
Factset Street Account